Lighten up
By NATIONAL CANCER RESEARCH CENTER
- CNIO
The accelerated aging of our population underscores the urgency to understand the molecular changes occurring in the body over time. The mTOR protein complex plays a critical role in many body functions, particularly in metabolism. A new study by CNIO researchers shows that even slight increases in mTOR activity can induce premature aging in animal models, reducing their lifespan by up to 20%.
This study, published in Nature Aging, provides insights into why diseases
associated with aging worsen in individuals with a high body mass index, an
indicator of obesity and inflammation. It also explains why calorie
restriction, known for extending lifespan in animals, promotes healthy aging by
activating specific genes that interact with mTOR.
Additionally, the study introduces a new
research tool designed “to study the relationship between nutrient increase and
the ageing of different organs,” according to lead author Alejo Efeyan, who
heads the Metabolism and Cell Signalling Group at the National Cancer Research
Centre (CNIO).
Manipulating mTOR in Animal Models
The activity of the mTOR protein complex is
regulated according to the amount of nutrients available in the cell. The
authors developed a method to manipulate mTOR activity in animal models by
targeting the protein that signals nutrient levels to mTOR. By genetically
modifying this protein to simulate higher nutrient levels, they triggered mTOR
to activate its pathway as if the animals were consuming more food, even though
their actual diet remained unchanged.
Consequences of
Enhanced mTOR Activity
When animals with the modified protein reach
maturity, their cellular functions begin to deteriorate, leading to aging
symptoms such as thinner skin and damage to organs like the pancreas, liver,
and kidneys. Immune system cells come to repair them but are overwhelmed by the
amount of damage. They accumulate and, instead of repairing, trigger
inflammation that further increases problems in those organs.
This cycle of damage and ineffective repair
shortens the animals’ lifespans by 20%, equivalent to about 16 years in humans.
Potential
Therapeutic Measures
The researchers aimed to disrupt this cycle
by inhibiting the immune response that causes inflammation. As a result, organ
damage improved enough to gain what in humans would be a few years of life.
First author Ana Ortega-Molina, who runs the
Metabolism in Cancer and Ageing Laboratory at CBM, notes that acting on chronic
inflammation is “a potential therapeutic measure that controls deterioration of
health.”
Potential Human
Implications
When the CNIO group manipulated mTOR to
simulate an excess of nutrients, the resulting changes mirrored those seen in
natural aging. They compared their model to colonies of naturally aging mice,
including both their own and those maintained by the National Institute on
Aging (NIA).
For example, the activity of lysosomes, which
are the organelles with which the cell removes and recycles its waste, is
reduced in both naturally aged and genetically modified animals. “When there is
an excess of nutrients it makes sense that the cell shuts down the recycling
activity of lysosomes, because this recycling operates especially when there
are no nutrients,” Efeyan says.
This decrease in lysosomal activity also
occurs in human aging, as verified by the group from the University of Valencia
when contrasting blood samples from young people and septuagenarians.
A New Tool
Beyond this paper, Efeyan believes that this
new animal model offers “ample fertile ground to ask more questions about how
nutrient increase, or their signalling, facilitates processes in the different
organs that allow us to understand their ageing in particular. Or, for example,
investigate the relationship with neurodegenerative diseases, because there is
some inflammation in the central nervous system. It’s a tool that many more
people can use.”
Additional co-authors include Rafael de Cabo
of the National Institute on Aging (NIA) in Bethesda, USA, Consuelo Borrás and
Daniel Monleón, from the University of Valencia, and María Casanova-Acebes,
head of the Cancer Immunity group at CNIO.
Reference: “A mild increase in nutrient
signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation
and shortened lifespan” by Ana Ortega-Molina, Cristina Lebrero-Fernández, Alba
Sanz, Miguel Calvo-Rubio, Nerea Deleyto-Seldas, Lucía de Prado-Rivas, Ana Belén
Plata-Gómez, Elena Fernández-Florido, Patricia González-García, Yurena
Vivas-García, Elena Sánchez García, Osvaldo Graña-Castro, Nathan L. Price,
Alejandra Aroca-Crevillén, Eduardo Caleiras, Daniel Monleón, Consuelo Borrás,
María Casanova-Acebes, Rafael de Cabo and Alejo Efeyan, 7 June 2024, Nature Aging.
DOI:
10.1038/s43587-024-00635-x
This work has been funded by, among others,
the Spanish Ministry for Science, Innovation and Universities, the Spanish
Research Agency, the European Regional Development Fund, the Spanish
Association Against Cancer Research Scientific Foundation, “la Caixa” Banking
Foundation, Olivia Roddom Oncology Research Grant, Intramural Research Program
at the NIA, National Institutes of Health. Yurena Vivas, one of the
authors, is a beneficiary of a CNIO Friends contract funded by the Domingo
Martinez Foundation.